<qa>  What is a neurological disorder that might affect any efficacy assessments?27. Any neurological congenital or acquired, vascular, or systemic disorder that might affect any of the efficacy assessments, in particular, joint pain and swelling e.g., Parkinsons disease, cerebral palsy, diabetic neuropathy. 